- Rapid Dose Therapeutics press release ( OTCPK:RDTCF ): Q3 GAAP EPS of -C$0.01.
- Revenue of C$61.77K (-92.5% Y/Y).
For further details see:
Rapid Dose Therapeutics GAAP EPS of -C$0.01, revenue of C$61.77Khome / stock / rdtcf / rdtcf news
For further details see:
Rapid Dose Therapeutics GAAP EPS of -C$0.01, revenue of C$61.77KMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Rapid Dose Therapeutics Corp Company Name:
RDTCF Stock Symbol:
Market:
Rapid Dose Therapeutics Corp Website:
Burlington, Ontario--(Newsfile Corp. - July 22, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (" RDT " or the " Company ") is pleased to announce that it has closed a first tranche of its previously announced equity private placement financing (the " Financing ") for aggregate gross proceeds ...
Burlington, Ontario--(Newsfile Corp. - July 2, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (" RDT " or the " Company ") announced today that as contemplated in the secured convertible notes (the " Notes ") previously issued on its private placement financing (the " Financing "), the Company...
Burlington, Ontario--(Newsfile Corp. - July 2, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (" RDT " or the " Company "), is pleased to announce the filing of its financial results for the year ended February 29, 2024. Mark Upsdell, Chairman and Chief Executive Officer, stated, "Over ...